View in EDS HTML Full Text PDF Full Text

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Saved in:
Bibliographic Details
Title: Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.
Authors: Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Park YH; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Singer CF; Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Balmaña J; Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain., Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan VK; Division of Surgery and Surgical Oncology, Department of Breast Surgery, National Cancer Centre Singapore, Singapore, Singapore., Mulansari NA; Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia., Yusof MM; Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia., Que FVF; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines., Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Parinyanitikul N; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Pham CP; Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam., Taib NA; Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia., Kong SY; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Republic of Korea., Antill Y; Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Source: Frontiers in oncology [Front Oncol] 2025 Jun 23; Vol. 15, pp. 1507836. Date of Electronic Publication: 2025 Jun 23 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40626014
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Park+YH%22">Park YH</searchLink>; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Singer+CF%22">Singer CF</searchLink>; Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Balmaña+J%22">Balmaña J</searchLink>; Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dent+RA%22">Dent RA</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+VK%22">Tan VK</searchLink>; Division of Surgery and Surgical Oncology, Department of Breast Surgery, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mulansari+NA%22">Mulansari NA</searchLink>; Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia.<br /><searchLink fieldCode="AU" term="%22Yusof+MM%22">Yusof MM</searchLink>; Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia.<br /><searchLink fieldCode="AU" term="%22Que+FVF%22">Que FVF</searchLink>; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines.<br /><searchLink fieldCode="AU" term="%22Lu+YS%22">Lu YS</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Parinyanitikul+N%22">Parinyanitikul N</searchLink>; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Pham+CP%22">Pham CP</searchLink>; Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Taib+NA%22">Taib NA</searchLink>; Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.<br /><searchLink fieldCode="AU" term="%22Kong+SY%22">Kong SY</searchLink>; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Antill+Y%22">Antill Y</searchLink>; Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink>; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Jun 23; Vol. 15, pp. 1507836. <i>Date of Electronic Publication: </i>2025 Jun 23 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40626014
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1507836
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1507836
    Titles:
      – TitleFull: Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee SC
      – PersonEntity:
          Name:
            NameFull: Park YH
      – PersonEntity:
          Name:
            NameFull: Singer CF
      – PersonEntity:
          Name:
            NameFull: Balmaña J
      – PersonEntity:
          Name:
            NameFull: Dent RA
      – PersonEntity:
          Name:
            NameFull: Tan VK
      – PersonEntity:
          Name:
            NameFull: Mulansari NA
      – PersonEntity:
          Name:
            NameFull: Yusof MM
      – PersonEntity:
          Name:
            NameFull: Que FVF
      – PersonEntity:
          Name:
            NameFull: Lu YS
      – PersonEntity:
          Name:
            NameFull: Parinyanitikul N
      – PersonEntity:
          Name:
            NameFull: Pham CP
      – PersonEntity:
          Name:
            NameFull: Taib NA
      – PersonEntity:
          Name:
            NameFull: Kong SY
      – PersonEntity:
          Name:
            NameFull: Antill Y
      – PersonEntity:
          Name:
            NameFull: Kim HJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 06
              Text: 2025 Jun 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1